TIIEX
Price
$17.00
Change
+$0.02 (+0.12%)
Updated
Jun 16 closing price
Net Assets
5.54B
VTIAX
Price
$46.45
Change
-$0.22 (-0.47%)
Updated
Jun 16 closing price
Net Assets
652.3B
Interact to see
Advertisement

TIIEX vs VTIAX

Header iconTIIEX vs VTIAX Comparison
Open Charts TIIEX vs VTIAXBanner chart's image
TIIEX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
TIIEX vs. VTIAX commentary
Jun 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TIIEX is a Hold and VTIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 652B vs. TIIEX (5.55B). TIIEX pays higher dividends than VTIAX: TIIEX (2.77) vs VTIAX (2.63). TIIEX was incepted earlier than VTIAX: TIIEX (27 years) vs VTIAX (16 years). TIIEX (0.45) is less costly to investors than VTIAX (0.09). TIIEX is a more actively managed with annual turnover of: 25.00 vs. VTIAX (4.00). VTIAX has a lower initial minimum investment than TIIEX: VTIAX (3000) vs TIIEX (1000000). VTIAX annual gain was more profitable for investors over the last year : 28.29 vs. TIIEX (13.97). VTIAX return over 5 years is better than : 36.25 vs. TIIEX (30.46).
TIIEXVTIAXTIIEX / VTIAX
Total Expense Ratio0.450.09500%
Annual Report Gross Expense Ratio0.450.09500%
Fund Existence27 years16 years-
Gain YTD7.94715.19452%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets5.55B652B1%
Annual Yield % from dividends2.772.63106%
Returns for 1 year13.9728.2949%
Returns for 3 years41.4856.5073%
Returns for 5 years30.4636.2584%
Returns for 10 years92.21114.0781%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAH227.721.32
+0.58%
Cardinal Health
HESM37.17-0.29
-0.77%
Hess Midstream LP
RHLD124.31-7.39
-5.61%
Resolute Holdings Management
LOVE14.26-1.38
-8.82%
Lovesac Company (The)
KTTA0.51-0.05
-8.93%
Pasithea Therapeutics Corp